Phase 2 of new ARVs - Table of Contents
Fostemsavir, prodrug of temsavir (attachment inhibitor)
AI438011 Study

TAF (TFV prodrug)
Study 292-0102
Study 299-0102
Doravirine (non nucleoside reverse transcriptase inhibitor)
MK1439007 Study

Cabotegravir (integrase inhibitor)
LATTE Study

Bictegravir
BIC Phase 2 Study

BMS-955176 (maturation inhibitor)
AI468002 Study
Copyright AEI 2017 | Links | Contact | Faculty and Disclosure | Terms of use aei